Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 4/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.39 |
| ▸ | GABRE | P78334 | 2/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL88209 | 1.00 | CYP1A2 (0.44) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL20677353 | 0.85 | TSHR (0.40) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL14037307 | 0.85 | TSHR (0.40) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL5197097 | 0.85 | ADRA1A (0.48) | ALDH1A1TSHRHSD17B10LMNA | |
| SCHEMBL9335787 | 0.84 | ECE1 (0.44) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL31000621 | 0.82 | ALDH1A1 (0.41) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL29138980 | 0.80 | ALDH1A1 (0.40) | CYP1A2ALDH1A1THRBTSHRHSD17B10 | |
| SCHEMBL20814002 | 0.80 | TSHR (0.48) | ALDH1A1THRBTSHRHSD17B10LMNA | |
| SCHEMBL7362273 | 0.80 | TSHR (0.48) | ALDH1A1THRBTSHRHSD17B10LMNA | |
| SCHEMBL2179403 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010100589-A1 | TASTE MODIFYING COMPOUND | FIRMENICH SA (CH) | 2010-09-10 | — | — | WO | claimed |
| US-20260014265-A1 | TRIPLE-PAYLOAD ANTIBODY-DRUG CONJUGATES (ADCs) | ARARIS BIOTECH AG (CH) | 2026-01-15 | — | — | US | disclosed |
| EP-4604726-A1 | ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH | Ecolab USA Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024086642-A1 | ENHANCED YEASTICIDAL EFFICACY OF LACTIC ACID BASED ANTIMICROBIAL HANDWASH | ECOLAB USA INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| EP-4097209-A1 | AMYLASE SYNERGY WITH OXYGEN BLEACH IN WAREWASH APPLICATION | Ecolab USA Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| WO-2021155135-A1 | AMYLASE SYNERGY WITH OXYGEN BLEACH IN WAREWASH APPLICATION | ECOLAB USA INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| WO-2018143923-A1 | AMINE SYNERGISTS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2018-08-09 | — | — | WO | disclosed |
| EP-1412515-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | Genset (FR) | 2004-04-28 | — | — | EP | disclosed |
| WO-2002066672-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | GENSET S.A. (FR) | 2002-08-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014265-A1 | TRIPLE-PAYLOAD ANTIBODY-DRUG CONJUGATES (ADCs) | TOP2A, TOP1, TOP2B | CYP1A2 3490/4885ALDH1A1 2863/4885THRB 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.